药物临床试验登记与信息公示平台数据显示,Eli Lilly and Company、礼来苏州制药有限公司、Lilly del Caribe, Inc.的一项在伴有脂蛋白(a)水平升高且发生过动脉粥样硬化性心血管事件或发生首次动脉粥样硬化性心血管事件风险升高成人中评价Muvalaplin对主要不良心血管事件影响的III期、随机、双盲、安慰剂对照研究 - MOVE - Lp(a)已启动。临床试验登记号...
Source Link药物临床试验登记与信息公示平台数据显示,Eli Lilly and Company、礼来苏州制药有限公司、Lilly del Caribe, Inc.的一项在伴有脂蛋白(a)水平升高且发生过动脉粥样硬化性心血管事件或发生首次动脉粥样硬化性心血管事件风险升高成人中评价Muvalaplin对主要不良心血管事件影响的III期、随机、双盲、安慰剂对照研究 - MOVE - Lp(a)已启动。临床试验登记号...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.